ArticleESMO open2022

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.

L Cantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.